Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
    2.
    发明授权
    Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses 有权
    来自人B细胞并具有针对甲型流感病毒的中和活性的人单克隆抗体

    公开(公告)号:US09573991B2

    公开(公告)日:2017-02-21

    申请号:US13583529

    申请日:2011-03-07

    摘要: The present invention relates to human monoclonal antibodies derived from human B cells present in the blood of patients who had recovered from infection with influenza A viruses, wherein the monoclonal antibodies have neutralizing activity against influenza A viruses. The anti-influenza A virus monoclonal antibody of the present invention has binding and neutralizing activities against at least one influenza A virus selected from the group consisting of influenza A virus H1, H2 and H5 subtypes, and thus it is useful for the prevention and treatment of a disease caused by the influenza A virus and is also useful for diagnosis of influenza A virus infection.

    摘要翻译: 本发明涉及从甲型流感病毒感染中恢复的患者血液中存在的人B细胞的人单克隆抗体,其中所述单克隆抗体具有针对甲型流感病毒的中和活性。 本发明的抗A型流感病毒单克隆抗体对选自甲型流感病毒H1,H2和H5亚型的至少一种甲型流感病毒具有结合和中和活性,因此可用于预防和治疗 由甲型流感病毒引起的疾病,也可用于甲型流感病毒感染的诊断。